Grasedieck and colleagues proposed that NRIP1 expression in AML bone marrow tissues was up-regulated by the regulation of the AML marker oncogene EVI1, which was unique to patients with abnormal chromosome 3 [32]. This evidence concerns the gene NRIP1 and acute myeloid leukemia.